Select the Industry/ Sector 👉    All Industries

Top Pharmaceuticals & Drugs Industry Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹21,892.4
₹46,520 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,346.1
₹40,008 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹1,290.0
₹16,243 Cr
Pharmaceuticals & Drugs
₹546.6
₹10,743 Cr
Pharmaceuticals & Drugs
₹447.3
₹4,142 Cr
Pharmaceuticals & Drugs
₹273.9
₹3,062 Cr
Pharmaceuticals & Drugs
₹66.6
₹1,710 Cr
Pharmaceuticals & Drugs
₹567.3
₹324 Cr
Pharmaceuticals & Drugs
₹21.3
₹163 Cr
Pharmaceuticals & Drugs
₹61.5
₹129 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,346.1
₹11,599 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Good [Stock is Cheap]
Debt : Average
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹546.6
₹5,653 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹1,290.0
₹3,743 Cr
Pharmaceuticals & Drugs
₹447.3
₹2,716 Cr
Pharmaceuticals & Drugs
₹273.9
₹541 Cr
Pharmaceuticals & Drugs
₹21.3
₹180 Cr
Pharmaceuticals & Drugs
₹66.6
₹127 Cr
Pharmaceuticals & Drugs
₹61.5
₹88 Cr
Pharmaceuticals & Drugs
₹567.3
₹342 Cr
Pharmaceuticals & Drugs
₹21,892.4
₹5,353 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,346.1
₹1,007 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹1,290.0
₹588 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Good [Stock is Cheap]
Debt : Average
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹546.6
₹373 Cr
Pharmaceuticals & Drugs
₹447.3
₹166 Cr
Pharmaceuticals & Drugs
₹273.9
₹104 Cr
Pharmaceuticals & Drugs
₹66.6
₹81 Cr
Pharmaceuticals & Drugs
₹21.3
₹15 Cr
Pharmaceuticals & Drugs
₹61.5
₹5 Cr
Pharmaceuticals & Drugs
₹567.3
₹36 Cr
Pharmaceuticals & Drugs
₹21,892.4
₹949 Cr

You may also like the below Video Courses